future endeavours with adcs in bladder cancer
Published 1 year ago • 53 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
2:19
what are the latest in adcs for prostate and bladder cancer?
-
2:30
the future of antibody-drug conjugates in urothelial cancer
-
1:17
exploring ctdna in muscle-invasive bladder cancer: future applications and current limitations
-
0:55
adcs for advanced urothelial carcinoma
-
1:58
what’s next for antibody drug conjugates in urothelial carcinoma?
-
0:44
antibody-drug conjugates for advanced bladder cancer
-
0:54
where do adcs fit in the treatment landscape of urothelial carcinoma?
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
1:44
adcs in the treatment landscape of patients with advanced uc
-
2:12
looking towards the future: what is in store for the treatment of bladder cancer?
-
1:32
antibody-drug conjugates in urothelial carcinoma
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
2:06
the financial impact of bladder cancer
-
0:51
future of urothelial carcinoma research
-
0:52
what are the latest biomarkers for urothelial carcinoma?
-
1:23
cdh1-mutated clinically advanced urothelial bladder cancer: real-world clinical outcome study
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
2:07
adcs: is chemotherapy dead?
-
1:25
promising new adcs